Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Cancer

Advanced Noninvasive Tools for the Diagnosis of Cardiac Amyloidosis: What’s Their Role?
January 14, 2021/Cancer/Benign Hematology

Combination Therapy Triggers Complete Hematological Response in Amyloidosis Patient

Finally, promising new therapies for this difficult disease

breast cancer metastases
January 12, 2021/Cancer/Radiation Oncology

Case Study: Hyperthermia with Reirradiation Part of Multimodal Therapy for Oligometastatic Breast Cancer Patient

Innovative treatments control cancer recurrence

Myelofibrosis cells
January 7, 2021/Cancer/Blood Cancers

Pacritinib Moves Closer to FDA Approval for Myelofibrosis

Dose-finding trial adds to evidence of efficacy

Zebrafish embryo
December 31, 2020/Cancer

Zebrafish Models Fuel Study of Pediatric Neutropenias

Unique model is an excellent genetic animal model for study of lethal diseases

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

2015058_11-20-20_025_MK-Hero_650x450
December 30, 2020/Cancer

Cleveland Clinic Surgeon Completes First Clinical Use of Newly Approved Ablation Device for Large Liver Tumors

The technology could reduce complications by offering patients an alternative to open liver surgeries

nci-vol-2336_650x450

Machine Learning Improves the Subclassification and Prognostication of Acute Myeloid Leukemia

Four genomic clusters identified

Infusion
December 18, 2020/Cancer/News & Insight

Combination Therapy for AL Amyloidosis Safe, Tolerable and Promising in Early Results

Cael-101 + CyBorD dosing and outcomes

hematopoetic-cells_650x450
December 14, 2020/Cancer/Blood Cancers

Decision Support Tool Can Predict Patient Response to Treatment with Hypomethylating Agents

A major advance in prognosis for myelodysplastic syndromes that may improve outcomes

CAR T-cell therapy

Metabolomic Screening Reveals Pre-Existing Signatures in Patients Treated with CAR T-Cell Therapy

Molecular markers could potentially predict major adverse side effects

650×450-invasive-lobular-breast-cancer
December 9, 2020/Cancer/Tumor Oncology

Invasive Lobular Breast Cancer May Have Worse Prognosis than Ductal Cancer

Multi-institutional registry analysis highlights need for further research

BackPage 47 of 87Next

Advertisement

Ad